Full-Time

Quality Assurance

Validation Engineer

Posted on 2/27/2025

Agilent Technologies

Agilent Technologies

10,001+ employees

eProcurement services for streamlined purchasing

Compensation Overview

$97.9k - $153k/yr

+ Bonus + Stock

Mid, Senior

Company Does Not Provide H1B Sponsorship

Fort Lupton, CO, USA + 1 more

More locations: Boulder, CO, USA

Category
QA & Testing
Quality Assurance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Knowledge of GMP guidelines as well as international regulations pertaining to the production of APIs and drug products including, but not limited to, ICH, 21 CFR 210 and 211, 21 CFR Part 11, the FDA guidance on Process Validation, the EMA guidance on Process Validation, the Global Harmonization Task Force on Process Validation, EudraLex and GAMP 5.
  • Skill in written and verbal communications. Ability to efficiently respond to inquiries or complaints from customers, co-workers, subordinates, and supervisors regarding products and processes.
  • Excellent teamwork and problem-solving skills. Ability to collaborate with cross functional teams to assess changes and nonconformances for impact to validation and to drive validation program improvements.
  • Knowledge of statistical methods for use in validation analysis and review.
  • Knowledge of and skill in using computer software and hardware applications. Must be proficient with MS Word, MS Excel, and the use of computerized statistical tools.
  • Skill in time, priority, and project management. Must be able to use individual discretion in completing work assignments while assisting the group in establishing priorities, setting standards and working collaboratively to accomplish deadlines and objectives.
  • Ability to read, analyze, and interpret industry related periodicals, SOPs, and government regulations. Ability to write reports, business correspondence, and procedures.
  • Experienced in working with validation programs (equipment, cleaning, utility, computer, process, etc.), nonconformance investigations, CAPA, and change control programs.
Responsibilities
  • Provide Quality oversight of validation programs. Influences, develops, and/or implements improvements to validation programs in partnership with impacted departments to ensure the program maintains compliance with current regulatory and industry expectations.
  • Partner with Engineering Validation to define, implement, and improve Validation Policies and SOPs.
  • Provide the Quality Assurance (QA) review and approval for validation documentation, including but not limited to user requirement specifications; commissioning documentation; validation protocols and reports; change control documentation; process monitoring/review reports; automated systems method reviews.
  • Participate in risk assessments associated with process design and validation activities.
  • Collaborate with cross-functional teams to ensure overall project timelines and site validation objectives are met. Partner with Engineering, Manufacturing, Information Technology (IT), Technical Services, Facilities, Process Development and others as needed to prioritize and schedule validation activities.
  • Provide Validation guidance, training, and/or direction to other departments with respect to regulatory requirements as well as Agilent policies and SOPs.
  • Assist other departments in evaluating and resolving challenges and discrepancies encountered during validation.
  • Review and Approve Nonconformance Investigations, Corrective Action / Preventive Actions (CAPAs) and Change Controls related to validation activities.
  • Together with other area experts, act as a validation subject matter expert for client and regulatory audits.
  • Ensure that changes to the facility, utilities, equipment, cleaning, and computerized systems are thoroughly evaluated to determine the necessity of additional validation activities post-implementation.
Desired Qualifications
  • Bachelor's or Master's degree or equivalent engineering or related life sciences field
  • 4+ years of validation related experience; or equivalent combination of education and experience
  • Requires in-depth knowledge and experience in job and ability to work independently

Agilent Technologies provides electronic procurement services that help businesses streamline their purchasing processes. Their main offerings include a suite of eProcurement services that allow clients to integrate their pricing into existing platforms, access a hosted catalog, and conduct transactions without paper. This system is designed to help businesses quickly find and purchase the products they need at the right price, enhancing productivity through automation and simplified workflows. Unlike many competitors, Agilent focuses on providing tailored solutions that improve connectivity and efficiency, ultimately reducing costs and increasing profitability for clients. The goal of Agilent Technologies is to support a diverse range of businesses by delivering reliable and high-quality eProcurement solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisitions like Sigsense enhance Agilent's AI capabilities in lab operations.
  • The trend towards paperless transactions boosts Agilent's service efficiency and appeal.
  • Automation in procurement is expected to increase, benefiting Agilent's offerings.

What critics are saying

  • Integration challenges from acquiring BIOVECTRA may disrupt Agilent's operations.
  • Multiple acquisitions could stretch Agilent's resources and management focus.
  • Increased competition from funded companies like RareCyte and Elegen may challenge Agilent.

What makes Agilent Technologies unique

  • Agilent offers a comprehensive suite of eProcurement services for streamlined purchasing.
  • The company focuses on automation and paperless transactions to enhance business productivity.
  • Agilent's hosted catalog and pricing integration simplify procurement processes for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

5%
Business Wire
Jul 30th, 2024
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.

Biovectra
Jul 22nd, 2024
Agilent Technologies to Acquire BIOVECTRA Inc., Creating New Synergistic Opportunities to Improve Patient Care | BIOVECTRA

CHARLOTTETOWN, Prince Edward Island and SANTA CLARA, California – July 22, 2024 BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development and Manufacturing Organization, from H.I.G. Capital for $925 million. The acquisition provides the ability to expand the range of [...]Read More...

Finsmes
Jun 27th, 2024
RareCyte Secures $20M Financing

RareCyte, a Seattle, WA-based Life Sciences company providing precision biology platforms including instruments, reagents, software, and services, raised $20M in funding

Business Wire
May 14th, 2024
Elegen Raises $35 Million In Series B To Accelerate Expansion Into Clinical Manufacturing

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA synthesis and production, today announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round are strategic investors GSK, which recently entered a collaboration and licensing agreement with Elegen to use their proprietary cell-free DNA manufacturing technology in developing GSK’s vaccines and medicines, and John Ballantyne, co-founder of Aldevron. Elegen’s current investors, including Andreessen Horowitz (a16z Bio + Health), KdT Ventures, 8VC, Digitalis Ventures, ACVC Partners, Alix Ventures, AME Cloud Ventures and Agilent Technologies, also participated. The new funds will accelerate the extension of the company’s rapidly growing ENFINIA™ DNA product line across clinical workflows providing turnkey production of GMP-compliant DNA for clinical development of genetic medicines. “The age of genetic medicines is here, but these powerful modalities require innovative new manufacturing approaches to supply the critical input DNA material for rapid discovery, development and then wide-scale production,” said Matthew Hill, Ph.D., Elegen Founder and CEO. “With this investment, we will continue to push the boundaries of DNA synthesis to accelerate upstream discovery and enable rapid and streamlined deployment of new clinical modalities.”

GenomeWeb
Apr 3rd, 2024
Biofidelity Raises $24M to Expand US Commercialization of Lung Cancer Test, Product Pipeline

The firm said it also plans to use the money, which brings its total raised to $60 million, to establish a dedicated manufacturing facility in the UK.

INACTIVE